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1. GENERAL INTRODUCTION 
 
The trillions of microbes inhabitant the human intestine. The human gut microbiota is a 
complex ecological community that through its metabolic activities and interactions with host 
organism influences normal physiology and pathological processes. The intestinal microbiota 
performs important vital functions, such as barrier function, metabolic activity, trophic effect 
and maturation of the adaptive and innate immune responses of the host organism.  
Colonization of the human gut starts after birth and it is a dynamic ecosystem. Usually, it 
stabilizes during the first 2-5 years. During the life gut microbiota composition increases in 
diversity and richness, and reaches the highest complexity in the human adult. At the late 
stages of human life diversity of gut microbiota becomes more dynamic. Next factors like 
alterations in lifestyle, nutritional behavior, inflammatory diseases and infections, ageing of 
human organism may affect the composition and activity of the gut microbiota, but the course 
and mechanisms behind these changes are not yet completely understood. Characterization of 
changes in gut microbial diversity during life-time is the first step in elucidating its role in 
health and disease. Also, this knowledge is important for promotion effective therapeutic 
strategy against different diseases. Investigation into structural changes and composition 
evolution from infants to the elderly has only recently begun. Very little information is 
available pertaining to possible variations that occurs with ageing. 
The most studies published on quantity of intestinal microbiota are associated with different 
human diseases. Thus, the aim to expand our understanding of the intestinal microbiita 
including its establishment, composition, and evolution in healthy persons in different age 
groups and to output the approximate norm of the gut microbial composition in healthy 
persons. In the future studies, the obtained data gives opportunity to make comparative 
analysis between human gut microbial composition in health and disease.  
This study was performed at the Department of Microbiology, Tartu University. 
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1.1 Microbiota of human gastrointestinal tract. 
 
The human intestinal tract harbours a large, active and complex community of microbes of 
different microbial ecosystems that vary according to their location within the gastrointestinal 
tract (GIT) (Tannock, 2002; Janet et al., 2008). Gut microbial diversity in healthy adults 
varies widely between studies that report between abundance reach 1014 cells/g of luminal 
content, 1000 to 35,000 species depending largely on methods applied (Eckburg et al., 2005; 
Frank et al. 2008; Human genome project, 2010). The microbial composition and relative 
their relative proportion varies with different parts of GIT (Figure 1). Human mouth is 
colonized by members of Actinomyces sp., Corynebacterium sp., Lactobacillus sp., 
Fusobacterium sp., Veillonella sp., Staphylococcus sp., Streptococcus sp. and one Archaea 
type, and considered to be the major population of upper part of the GIT (108 CFU/g) 
(Zilberstein et al., 2007). In addition, the aviability of oxygen varied in different parts of the 
mouth which allows the growth of anaerobic and aerobic bacteria with the ratio 1:10 
(Zilberstein et al., 2007, Human genome project, 2010). Majority of bacterial species from 
human mouth belong to Streptococcus sp. and Veillonella sp. (Figure 1). They have ability of 
adherence to various surfaces such as teeth, oral mucosa or tongue. The oral cavity is 
colonized also by yeasts such as Candida sp. (Zilberstein et al., 2007).  
The microbiota of the esophagus is colonized by allochthonous organisms. Such transitory 
microbiota does not occupy a niche but pass through the esophagus. Mainly it consists of the 
same bacteria as those found in the mouth – mostly Streptococcus sp. with 40% frequency, 
Staphylococcus sp. with 20% frequency, Corynebacterium sp., Lactococcus sp. and 
Peptococcus sp. with 10% frequency respectively (Figure 1) (Zilberstein et al., 2007; Janet et 
al., 2008). However, the microbial diversity is smaller in the esophagus in comparison to the 
mouth.  
The secretory activity of the stomach and duodenum affects significantly the number of 
microorganisms in these parts of the GIT by influence of low gastric pH (pH 1.0-2.0 units). In 
stomach and duodenum the abundance of microorganisms is less than 104 CFU/g (Figure 1). 
Lactobacillus sp., Veillonella sp., Clostridium sp. and pathogen Helicobacter pylori, as the 
microorganisms colonizing acidic environment, are the main residents of the stomach and 
duodenum (Zilberstein et al., 2007). Moreover, 128 different bacterial phylotypes and few 
yeast species, such as C. albicans, were found in these parts of the GIT. About 50% of 128 
bacterial phylotypes is represented by uncultivated bacteria (Bik et al., 2006). 
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Figure. 1. A bacterial distribution in human gastrointestinal tract, adapted from Janet et al., 
2008 (bacterial counts are expressed in CFU/ml, colony forming units per ml). With alterations. 
Microbiota of the lower digestive tract includes microorganisms colonizing such parts of the 
GIT as the small intestine (jejunum and ileum), colon and rectum (Figure 1). Microbiota of 
these parts of digestive system is much more diverse and larger than the population of upper 
parts of the GIT. Significantly increased pH (gastric pH is 1.0-2.0 units while in the mucosa 
of the small intestine pH 8.0) positively affect the development of microbial diversity 
(Slizewska et al., 2008). Majority of human gut bacteria is anaerobic (facultative or obligate), 
however in the intestinal mucus environment favorable for growth of microaerophiles exist. In 
the adult human gut microbiota Bifidobacterium sp., Bacteroides sp., Clostridium sp. and 
Eubacterium sp. dominate less from the genus Lactobacillus, Escherichia, Enterobacter, 
Streptococcus and Klebsiella are found. Only 30% of predominant bacterial species are   
present in the gut of human, the rest 70% are unique and host-specific microorganisms 
(Libudzisz et al., 2008). 
Microbiota of the jejunum resembles the microbiota of the duodenum. There are bacteria of 
the genera Bacteroides, Lactobacillus and Streptococcus. Also, the yeast Candida albicans is 
present. The abundance is high (up to 107 CFU/g) (Stolarczyk et al., 2008). Similarly is in the 
ileum, although except from Bacteroides and Lactobacillus, bacteria belonging to genus 
Clostridium, Enterococcus, and Veillonella, and the family Enterobacteriaceae are also 
predominant. Microbial diversity in the cecum mainly consists of facultative anaerobic 
bacterial populations belonging to Lactobacillus-Enterococcus group and E.coli species. The 
count of strict anaerobes such as the Bacteroides, C.leptum and C.coccoides groups are 
significantly lower than in the colon (Marteau et al., 2001).  
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The population of microorganisms of colon and rectum is the highest in number (Libudzisz et 
al., 2008). In the large intestine, abundance of microorganisms is 1011 CFU/g, while in rectum 
can reach even 1014 CFU/g, which represents approximately 30% of its content (Slizewska et 
al., 2008). It has been demonstrated previously that majority of bacteria in colon 
predominantly belong to Bacteroides, Eubacteria, Clostridium, Ruminococcus, 
Fusobacterium, Bifidobacterium and Peptostreptococcus genus (Figure 1) (Eckburg et al., 
2005). 
 
1.2 Functions of the human intestinal microbiota 
Throughout the human lifetime, the intestinal microbiota performs vital functions, such as 
barrier function, metabolic reactions (fermentation of nondigestible fibers, salvage of energy 
as short-chain fatty acids, and production of vitamins), trophic effect and maturation of the 
innate and adaptive immune responses of the host organism (Stolarczyk et al., 2008;; 
Libudzisz et al., 2008; Sekirov et al., 2010). 
Intestinal microorganisms have a beneficial effect on metabolic activity of the organism. 
Bacteria belonging to Firmicutes and Bacteroides phylum, is characterized by a high 
fermentation activity. The main representatives of type Firmicutes in colon belong to classes 
Bacilli and Clostridia. Class Bacilli produces lactic acid and acetic acid as a result of the 
saccharide fermentation. Class Clostridia, represented mostly by bacteria of the genus 
Clostridium and Eubacterium, characterizes in proteolytic and saccharolytic ability producing 
organic acids such as lactic, butyric, acetic, and formic. The fermentation activity of bacteria 
belonging to Bacteroides type is also very high. These bacteria produce in high counts organic 
acids such as acetic, succinic, lactic, formic, propionic, and less butyric, isobutyric and 
isovaleric (Figure 2) (Stolarczyk et al., 2008). The metabolic activity leads to the 
accumulation of energy and absorbable substrates for the host organism, what is important for 
providing energy and nutrients for life-sustaining activity of bacteria. Fermentation of 
saccharides is the main source of energy for intestinal epithelial cells (Guarnen et al., 2003). 
The end products of saccarides metabolism are short chain fatty acids (SCFA). SCFA are 
importaint in stimulating cell proliferation, differentiation of intestinal enterocytes, therefore 
ensuring the control of integration of the small and large intestine epithelium. In addition, 
SCFA affect mineral balance and regulate the metabolism of glucose and lipids (Libudzisz et 
al., 2008). Intestinal bacterial community also take part in the synthesis of vitamins (e.g. K, B, 
D), and absorption of calcium, magnesium and iron (Guarner et al., 2003). 
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Not all microorganisms colonizing the GIT affect positively to the human. Pathogens and 
microorganisms producing toxins have harmful influence on the host organism. These 
pathogens include some species of the genus Enterococcus, Streptococcus and Escherichia 
coli strains, which naturally exists in the human GIT. These pathogen strains can have 
negative impact when they dominant in this environment. Changes in composition of gut 
microbiota can be caused by many factors, such as gastrointestinal surgery, lesions of the 
colon, kidney and liver cancers, impaired immune system, antibiotic and radiological 
treatment, aging, poor diet, stress, change in body weight, such diseases as faecal pouchitis, 
ulcerative colitis (Guarner et al., 2003; Libudzisz et al., 2008). In the case of fecal pouchitis, 
number of bacteria of the genus Bifidobacterium and Lactobacillus is significantly reduced, 
while the number of Clostridium sp. increases. Such changes in microbiota composition cause 
the reduction of the concentrations of protein metabolism products and increase of the pH of 
intestine content. Ulcerative colitis causes reducing the number of Bifidobacterium sp. and 
increasing the number of bacteria belonging to the Enterobacteriaceae family. Such changes 
induce abnormal immune response to external antigens (allergens and pathogens), and even 
their own intestinal bacteria (Libudzisz et al., 2008). Function abnormalities of intestinal 
mucosa barrier can lead to the microorganism’s translocation from the GIT into other parts of 
the human body. Microorganisms can enter the lymph nodes, liver or spleen and cause sepsis, 
shock, organ failure and even death of the human (Berg et al., 2001). The diet rich in fats and 
high intakes of red meat сan lead the changes in the gut microbiota composition, and thus 
even to the tumor. Intestinal microorganisms significantly can be responsible for tumors in the 
kidneys, liver, ovary, and especially in the colon (Bindgham et al., 1999). Through the 
production and activation of carcinogens and genotoxic compounds, intestinal 
microorganisms may play an important role in development of neoplasia (Rieger et al., 1999).   
For many years, several groups of scientists focused their research on the relation between 
changes in composition of gut microbiota and obesity in children and adults. Two research 
groups: Backhed et al (Backhed et al., 2005) and Ley et al (Ley et al., 2006) demonstrated 
that the number of bacteria from Bacteroides phylum is higher in individuals with normal 
weight. In obese people the percentage of Firmicutes is higher than in lean, and thus their 
intestinal microbiota is characterized by a higher fermentation activity and better efficiency of 
digestion of food intake (Stolarczyk et al., 2008). Abdominal obesity (waist circumference in 
women >89cm, men >102cm) can lead to the development of metabolic syndrome, also 
known as insulin resistance syndrome. It is a set of interrelated factors, which cause the 
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atherosclerosis, type 2 diabetes and vascular complications (Torphy et al., 2006; 
Lewandowska 2010). The risk of the metabolic syndrome increases with age.  
 
Figure 2. Metabolism of saccharides in the human colon (Stolarczyk et al., 2008). 
 
1.3 Gut microbiota and immune system 
Gut microbiota plays important role in development of the intestinal mucosal and systemic 
immune systems. The mucosal immune system is composed of the gut-associated lymphoid 
tissue (GALT) and small intestinal lymphoid tissue (SILT) in the small intestine, lymphoid 
aggregates in the large intestine and diffusely spread immune cells in the lamina propria of the 
GIT. These immune cells are in contact with the rest immune system through the local 
mesenteric lymph nodes (MLNs) (Rakoff-Nahoum and Medzhittov, 2008). The mucosal 
immune system has two functions. Firstly, tolerance of overlying microbiota on prevention of 
detrimental induction and systemic immune response of the host. Secondly, control of the gut 
microbiota for prevention of overgrowth and translocation to the different parts of the human 
organism (Sekirov et al., 2010). The intestinal mucosa represents the largest surface area of 
the human body in contact with the antigens of the external environment. Intestinal mucosa 
contains immune cells with pattern recognition receptors, such as the TLRs (Toll-Like 
Receptors) and NOD (Nucleotide-binding Oligomerization Domain) -like receptors (NLRs). 
Intestinal epithelium plays role in generation of immune responses through selection of 
foreign antigens via TLRs and NLRs receptors (Rakoff-Nahoum and Medzhittov, 2008). 
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Bouskra et al. has shown that germ-free (GM) animals contain abnormal numbers of several 
immune system cell types and immune cell products. In adittion, GM animals have deficits in 
local and systemic lymphoid structures, decreased number of mature isolated lymphoid 
follicles (Bouskra et al., 2008), and reduced number of their IgA and IgG producing plasma 
cells (Macpherson and Harris, 2004). A major immune deficiency as abnormalities of 
proliferation of CD4+ and T-cell populations also has been shown. It has been shown that 
treatment of GM mice with capsular antigen PSA (bacterial PolySAccharide) of Bacteroides 
fragilis has restored the development of lymphocytes-containing spleen white pulp and 
stimulates proliferation of the CD4+ T-cells (Mazmanian et al., 2005). A complex microbial 
community containing proportion of bacteria from the Bacteroides phylum take part in the 
differentiation of inflammatory Th17 cells (Ivanov et al., 2008). Additionally, it has been 
shown that various Lactobacillus sp. differentially regulated DCs with consequent influence 
on the Th1/Th2/Th3 cytokine balance at the intestinal mucosa (Christensen et al., 2002). 
Peptidoglycans of Gram-negative bacteria have induced formation of isolated lymphoid 
follicles (ILF) via NOD1 (Bouskra et al., 2008).  
Prevention of excessive immune response to the bacteria from the gut microbiota can be 
achieved either through physical separation of bacteria and host cells: by modifications of 
antigenic moieties of the microbiota or modulation of localized host immune response 
towards tolerance (Sekirov et al., 2010). Resident immune cells of the GIT often have a 
phenotype distinct from cells of the same lineage found systemically. For instance, DCs found 
in the intestinal mucosa preferentially induce differentiation of resident T-cells into Th2 and 
Treg (regulatory T cells) subsets, therefore promoting a more tolerogenic environment in the 
GIT (Kelsall and Leon, 2005). 
 
1.4 Aging and gut microbiota 
The human gut microbiota starts to form after birth and it is a dynamic ecosystem, dominated 
by Bifidobacterium sp. Human gut microbiota usually stabilizes during the first 2-3 years 
(Koenig et al., 2011). During the life gut microbiota composition increases in diversity and 
richness (Scholtens et al., 2012) and reaches the highest complexity in the human adult, 
mainly composed of the bacteria from two phylas:  Bacteroidetes and Firmicutes (Rajilic-
Stojanovic et al., 2009). 
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1.4.1 Intestinal microbiota of newborns, infants and children 
Development of the intestinal microbiota in infants is characterized by rapid and large 
changes in microbial abundance, diversity and composition (Matamoros et al., 2012). The 
formation of the human gut microbiota begins during birth with colonization by 
microorganisms from mother and the environment (Bezirtzoglou et al., 1997). Changes in 
intestinal microbiota in infants are influenced by medical, cultural and environmental factors 
such as mode of delivery, type of infant feeding, gestational age, infant hospitalization, and 
antibiotic use by the infant (Penders et al., 2006, Drell et al., 2014). The intrauterine 
environment and newborn infant are sterile until delivery. Infant intestinal environment shows 
a positive oxidation/reduction potential, so gut is firstly colonized by facultative anaerobes, 
such as Escherichia coli, Streptococcus sp., Staphylococcus sp. and Enterococcus sp. The 
assimilating of oxygen by these bacteria changes the intestinal environment, permitting the 
growth of strict anaerobes, such as Bifidobacterium sp., Bacteroides sp. and Clostridium sp. 
(Bezirtzoglou, 1997). During the initial few months of a milk diet, bacteria such as 
Bifidobacteria can be prevailed (Sela et al., 2008). The introduction of solid food causes shift 
toward similar to adults microbiota (Palmer et al., 2007). Dutch study of fecal samples from 
1032 infants at 1 month of age were subjected to quantitative real-time PCR assays for the 
enumeration of total bacterial counts, Bifidobacterium sp., E. coli, Clostridium difficile, 
Bacteroides fragilis group, Lactobacillus sp. has showed that infants born through cesarean 
section had lower numbers of bacteria from Bifidobacterium genus from vaginally born 
infants and Bacteroides genus, whereas their gut was more often colonized with C. difficile, 
compared with vaginally born infants (Penders et al., 2006). Infants who were born vaginally 
at home and were breastfed have the most “beneficial” gut microbiota with highest numbers 
of bacteria from Bifidobacterium genus and lowest numbers of C. difficile, and E.coli 
(Penders et al., 2006). The gut of formula-fed infants was more often colonized with E.coli, 
C. difficile, Bacteroides sp. and Lactobacillus sp. compared with breastfed infants (Penders et 
al., 2006). Hospitalization and preterm birth were associated with higher numbers of 
C.difficile (Penders et al., 2006). Using of antibiotics in infants infant was associated with 
decreased numbers of Bifidobacterium sp. and Bacteroides sp. feces in comparison to non 
treated infants. Infants with older brothers and sisters had slightly higher counts of 
Bifidobacterium sp., compared with infants without siblings (Penders et al., 2006). 
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1.4.2 Intestinal microbiota of adults and elderly 
Adults gut microbiota composition is dominated by the phyla Bacteroidetes and Firmicutes 
(Rajilic-Stojanovic et al., 2009). At the late stages of life the microbiota composition becomes 
less diverse and more dynamic, characterized by a higher Bacteroides sp. to Firmicutes sp. 
ratio, increase in Proteobacteria sp. and decrease in Bifidobacterium sp. (Biagi et al., 2010). 
These changes in the bacterial composition are not clear-cut partially due to the various 
physiological changes during the life. These include factors such as alterations in lifestyle, 
nutritional behavior, increase of infection and inflammatory diseases and their medication. All 
of these factors will affect the composition and activity of the gut microbiota, but the 
mechanisms behind these changes are not yet completely understood (Ottman et al., 2012).  
In the study of Harmsen et al. (2000) adults’ intestinal microbiota were characterized with 
fluorescence in situ hybridization (FISH) method. According to the results, intestinal 
microbiota  of  adults have hierarchy of dominant (>109 CFU/g) anaerobic bacteria 
represented by the genera Bacteroides, Eubacterium, Bifidobacterium, Peptostreptococcus, 
Ruminococcus, Clostidium, Propionibacterium and sub-dominant bacteria (<109 CFU/g) of 
the Enterobacteriaceae family, especially  E.coli, and the genera Streptococcus, 
Enterococcus, Lactobacillus, Fusobacterium, Desulfovibrio and Methanobrevibacter 
(Harmsen et al., 2000). Results obtained by quantitative real-time PCR (qPCR) (Mariat et al., 
2009) showed that in adults, the Bacteroidetes and Firmicutes are the most prevalent phyla 
present, the latter of which combines the values obtained for the dominant Clostridium leptum 
and Clostridium coccoides groups and sub-dominant Lactobacillus group. The 
Bifidobacterium genus is present in eight to ten-fold lower numbers that the two major phyla. 
E.coli was found to be present as a sub-dominant population in adults, and it stabilizes at an 
intermediate level in seniors (Mariat et al., 2009).  
 
1.5 Methods for characterization of the human gut microbiota 
1.5.1 Bacteriological and biochemical methods 
Traditionally, analysis of the composition of the gut microbiota confide in the use of 
bacteriological methods such as cultivation on specific medium, microscopy and 
identification of the bacterial species (Janet et al., 2008). After isolation of colonies it is 
necessary to confirm the genus identity and make characterisation on the species level. For 
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bacterial species this characterisation requires a group of classical morphological and 
biochemical tests described in the Bergy’s Manual of Systematic Bacteriology (Bergey, 
1986). In addition, a bacterial count in the original sample is established by multiplying the 
number of colonies that develop with the degree of dilution. 
The great advantage of cultivation is that the isolates can be recovered and further studied for 
their ability to metabolise the different substances and also other physiological parameters.  
However, cultivation has several drawbacks. Firstly, only a small proportion of the bacterial 
community residing within intestinal tract can be cultivated with currently available 
approaches (Tannock et al., 2000; Eckburg et al., 2005). Secondly, the labour equipment and 
finances necessary for classical bacteriology are noticeably high thus limiting the 
effectiveness for analysing a large number of individuals. 
 
1.5.2 Molecular methods  
Traditional bacteriological methods recover less than 40% of the total bacterial species of the 
GIT, and the culturable portion of bacteria is not representative of the total phylogenetic 
diversity (Eckburg et al., 2005). Rapid nucleic acid amplification and detection technologies 
are quickly displacing the traditional assays based on microorganism phenotype rather than 
genotype. Molecular methods mainly based on ribosomal RNA (rRNA) and the encoded 
genes have revealed many intestinal bacterial species not previously described or cultivated 
(Suau et al., 1999; Zoetendal et al., 2001; Eckburg et al., 2005; Frank et al., 2007). Molecular 
methods for identification of comlex microbial ecosystems may are divided to qualitative, 
such as sequensing of 16S rRNA methods, fingerprints methods terminal restriction fragment 
length polymorphism (T-RFLP), phylogenetic microarrays, high-through sequencing, and 
quantitative, such as fluorescence in situ hybridization (FISH), real-time PCR (Figure 3) 
(Vaughan et al., 2000). 
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Figure 3. Molecular methods used for characterization of human intestinal microbiota, adapted 
from Biagi et al., 2012 
 
1.5.2.1 Real-time PCR 
Most frequently applied molecular approaches to quantify bacterial cells of human intestinal 
microbiota are real-time polymerase chain reaction (real-time PCR). PCR is the most 
commonly used nucleic acid amplification technique. The PCR process can be divided into 
three steps. First step is separation of double-stranded DNA (dsDNA) at temperatures above 
90°C. Second is annealing of oligonucleotide primers generally at 50-60°C, and, finally, 
optimal primers extension occurs at 70-78°C. The temperature at which the primer anneals is 
usually referred to as the Tm (Mackay et al., 2004). This is the temperature at which 50% of 
the oligonucleotide-target duplexes have formed. In case of real-time PCR, a chemiluminscent 
fluorescent reaction determines the kinetics of product accumulation during PCR 
amplification with specific primers for a specific group or species of bacteria. It is possible to 
use the product accumulation rate curves for calculation of number of original target 
molecules in a sample. The oligonucleotides are represented as a primer or a labelled probe. 
Another measure is denaturation temperature TD which refers to the Tm as it applies to the 
melting of dsDNA. The rate of temperature change or ramp rate, the length of the incubation 
at each temperature and the number of times for each cycle of temperatures is repeated and 
controlled by a programmable thermal cycler.  
There are different approaches for real-time PCR. One involves using DNA binding dyes such 
as SYBR Green I which are easy to design and optimize in an assay. Compared to non 
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specific chemistries for real-time PCR such as SYBR Green I, a higher level of detection 
specify is provided by using an internal probe together with a primer set to detect the product 
of interest. In the absence of the specific target sequence in the reaction, the fluorescence 
probe does not hybridize and therefore the fluorescence remains quenched. The level of 
fluorescence detected is directly related to the amount of amplified target in each PCR cycle 
(Wittwer et al., 2001). Another approach for the real-time PCR is Taqman methodology. It 
provides high level of quantitation and high specificity. The method uses the 5’nuclease 
activity of Taq polymerase to cleave a nonextendible hybridization probe during the extension 
phase of PCR. Taqman reaction requires a hybridization probe labeled with two different 
fluorescent dyes. One dye is a reporter dye (FAM, i.e., 66-carboxyfluorescein), the other is a 
quenching dye (TAMRA, i.e., 6-carboxy-tetramethylrhodamine) (Heid et al., 1997). Once the 
Taqman probe has bound to its specific piece of the template DNA after denaturation stage 
and the reaction cools, the primers anneal to the DNA. Taq polymerase then adds nucleotides 
and removes the Taqman probe from the template DNA. This separates the quencher from the 
reporter, and allows the reporter to give off it’s emit its energy. The more times the denaturing 
and annealing takes place, the more opportunities there are for the Taqman probe to bind and, 
in turn, the more emitted light is detected  
(http://www.lifetechnologies.com/ee/en/home/brands/molecular-probes.html). 
To quantify the amount of template present in a sample, it is necessary to create controls with 
a fixed number of templates. Standards are used to allow calculation of the amount of 
template present in a sample, while internal controls (ICs) are mostly used to determine the 
presence of false-negative reactions, examine the ability to amplify from a preparation of 
nucleic acids, and, quite rarely in real-time PCR, as a standard for quantification. It is very 
important to accurately determine concentration of the controls. Finally, the results of 
quantitation using a molecular control need to be expressed relative to a suitable biological 
marker, e.g., in terms of the volume of plasma, the number of cells of the mass of tissue or 
genomic nucleic acid, thus allowing to compare assay results and testing sites (Niesters, 
2001). Most commonly, an exogenous control is created using a cloned amplicon, a portion of 
the target organism’s genome, or simply purified amplicon itself (Borson, 1998). This control 
forms the basis of an external standard curve created from the data produced by the individual 
amplification of a dilution series of exogenous control. The concentration of unknown, which 
is amplified in the same reaction, but in a separate vessel, can then be found from the standard 
curve. 
17 
 
Fluorescence data generated by real-time PCR assays are generally collected from PCR cycles 
that occur within the linear amplification portion of the reaction, where conditions are optimal 
and the fluorescence accumulates in proportion to the amplicon (Figure 4) (Mackay et al., 
2002). The fractional cycle number at which the real-time fluorescence signal mirrors 
progression of the reaction above the background noise is used as an indicator of successful 
target amplification (Wilhelm et al., 2001). This is called the threshold cycle (CT), but a 
similar value is described for the LightCycler, and the fractional cycle is called the crossing 
point (CP). The CT is defined as the PCR cycle in which fluorescence generated by the 
accumulating amplicon exceeds ten standard deviations of the mean baseline fluorescence, 
using data taken from cycles 3–15 (Jung et al., 2000).The CT and CP are proportional to the 
number of target copies present in the sample (Gibson et al., 1996) and are assumed to 
represent equal amounts of amplicon present in each tube. The CT and CP values represent the 
fractional cycle number for each sample at a single fluorescence intensity value. The final CT 
and CP values are the fractional cycles at which a single fluorescence value (at or close to the 
noise band) traverses each sample’s plotted PCR curve (Wilhelm et al., 2001) (Figure 4). The 
accuracy of the CT or CP depends upon the concentration and nature of the fluorescence-
generating component, the amount of template initially present, the sensitivity of the platform, 
and the platform’s ability to discriminate.  
Real-time PCR is used for detection of nucleic acids from food, vectors used in gene therapy 
protocols, genetically modified organisms, and areas of human and veterinary microbiology 
and oncology (Mhlanga and Malmberg 2001; Klein et al., 2002; Ahmed, 2002;). 
 
Figure 4. Amplification curve of a real-time PCR adapted from Mackay et al., 2004 
 
Amplification curve plotted as fluorescence intensity against the cycle number is a sigmoidal 
curve. Early amplification cannot be viewed because the emissions are masked by the 
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background noise. When enough account of amplicon is present, the assay’s exponential 
progress can be monitored as the rate of amplification enters a linear phase (LP). Under ideal 
conditions, the amount of amplicon increases at a rate of one log10 every 3.32 cycles. As 
primers and enzyme become limiting, and products inhibitory to the PCR and overly 
competitive to oligoprobe hybridisation accumulate, the reaction slows, entering a transition 
phase (TP) and reaching a plateau phase (PP) where there is little or no increase in 
fluorescence. The point at which the fluorescence surpasses the noise threshold (dashed 
horizontal line) is called the threshold cycle or crossing point (CT or CP; indicated by an 
arrow), and this value is used in the calculation of template quantity during quantitative real-
time PCR. Also shown are curves representing a titration of template (Figure 4, dashed 
curves), consisting of decreasing starting template concentrations, which produce higher CT or 
CP values. The product accumulation rate curves allow backing calculating the number of 
original target molecules in a sample (Figure 4, dashed curves). Data for the construction of a 
standard curve are taken from the linear phase (Mackay, 2004). 
Real-time PCR method has some advantages and disadvantages. This method has high 
sensitivity and precise quantification of microbial species. However, this molecular tool 
allows detect only one target per experiment and only known microbial species (Biagi et al., 
2012). Ability to design primers for real-time PCR extends to knowledge of a 
microorganism´s genome as well as the ability of publicly available sequence databases to 
suitably represent all variants of that microbe (Mackay, 2004). 
Recently the publications about applying of multiplex real-time PCR have been appeared 
(Haarman and Knol 2006). The difference of this method is that multiple targets are amplified 
in a single reaction tube. Each target is amplified by a different set of primers, and a uniquely-
labeled probe distinguishes each PCR amplicon. Thus, it is possible to measure the expression 
levels of several targets or genes of interest more quickly. This method uses one or more 
primer sets to amplify multiple templates within a single reaction. However, multiplex real-
time PCR has proven problematic because of the limited number of fluorophores available for 
detection (Wittwer et al., 2001; Mackay et al., 2004). 
 
1.5.2.2 Another molecular methods 
 
One more molecular approach for quantifying bacterial cells in complex ecosystems is 
fluorescence in situ hybridization (FISH). This technique allows nucleic acid sequences to be 
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examined inside a cell without altering the cell’s morphology or integrity of its various 
compartments (Amann et al., 1995; Harmsen et al., 1999). The most commonly used target 
molecule for FISH is 16S rRNA. This method detects nucleic acid by fluorescently labeled 
probes that hybridize specifically to its complementary target sequence. This method 
combines the precision of molecular genetics with the visual information from microscopy. 
The procedure in the following steps: (I) fixation of the specimen, (II) preparation of the 
sample, possibly including specific pretreatment steps; (III) hybridization with the respective 
probes for detecting the respective target sequences; (IV) washing steps to remove unbound 
probes; (V) mounting, visualization and documentation of results (Moter and Göbel, 2000). 
The nucleotide probes used in FISH are generally between 15 and 30 nucleotides long and 
covalently linked at the 5’-end to a single fluorescent dye molecule. Common fluorophors 
include fluorescein, tetramethylrhodamine, Texas red and, increasingly, carbocyanine dyes 
like Cy3 or Cy5 (Southwick et al., 1990). In general, FISH allows quantitative analysis of the 
bacteria and has high sensitivity. However, this method has some disadvantages, such as false 
positive results due to autofluorescence of microorganisms themselves; insufficient probe 
penetration into the bacterial cell; limited number of used genus-or species-specific probes 
(Moter and Göbel, 2000). 
Nowadays, one of the widely used technologies in microbiology is pyrosequencing, a unique 
sequencing method that was developed as an alternative to classical DNA sequencing for 
short- to medium-read applications (60-200bp). This method is based on the detection of 
released pyrophosphate (PPi) during DNA synthesis. In a cascade of enzymatic reactions, 
visible light is generated that is proportional to the number of incorporated nucleotides. The 
cascade starts with a nucleic acid polymerization reaction in which inorganic PPi is released 
as a result of nucleotide incorporation by polymerase. The released PPi is subsequently 
converted to ATP by ATP sulfurylase, which provides the energy to luciferase to oxidize 
luciferin and generate light. Because the added nucleotide is known, the sequence of the 
template can be determined (Ronaghi, 2001). Compared to other, methods, it is highly 
quantitative and fast. Additional advantages include high accuracy, flexibility and ability to 
automate sample preparation (Novais and Thorstenson, 2011). The main disadvantage of 
pyrosequencing is a high cost of this method. 
More recently, the microarrays technology has been applied for the study of the diversity of 
human intestinal microbiota. Phylogenetic DNA microarrays consists of several thousand 
probes, usually designed from rRNA gene sequence database targeting either specific 
microorganisms (e.g. pathogenic bacteria) or the whole microbiota at various taxonomic 
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levels. Using of 16S rRNA microarrays technique provides superior diagnostic power 
compared to clone library (DeSantis et al., 2007). The main advantage of phylogenetic 
microarrays is a high resolution of microbial biodiversity and quantitative analysis of the 
entire microbial community (Biagi et al., 2012). Several microarrays addressing the gut 
microbiota have been developed, showing differences in their design and the aims of study. 
Palmer et al., 2007 have designed an array containing 10,265 probes, each spotted once, and 
targeting 1,629 species. Another microarray addressing the whole gut microbiota has been 
spotted with 16,223 probes targeting 775 bacterial species (Paliy et al., 2010). The Human 
Intestinal Tract Chip (HITChip) technology has targeted 1,140 microbial phylotypes (<98% 
identify) using 4,809 overlapping probes (Rajilic´-Stojanovic´ et al., 2009). The HuGChip 
technolog has been composed of 4,441 probes (2,442 specific and 1,919 explorative probes) 
targeting 66 bacterial families. This technology is able to detect not only known human gut 
microbiota species but also not yet described in the human gut microbiota (Tottey et al., 
2013). It is a high throughput platform used for studying numerous samples and detection 
thousands of nucleic acids sequences. 
Effective method for qualitative characterization of microbial community is terminal 
restriction fragment length polymorphism (T-RFLP). This approach involves tagging one end 
of PCR amplicons through using of a fluorescent molecule attached to a primer. Then 
restriction enzyme cuts the amplified product. Terminal restriction fragments (T-RFs) are 
separated by electrophoresis and visualized by emission of the fluorophore. T-RFLP analysis 
provides quantitative data about each detected terminal restriction fragment, including size in 
base pairs and intensity of fluorescence. T-RF sizes can be compared to a database of 
theoretical T-RFs derived from sequence information. T-RFLP profiles have been shown to 
be relatively stable to variability in PCR conditions (Blackwood et al., 2003). The 
disadvantage of this method is impossibility of quantitative analysis and no identification of 
bacteria at specie level (Biagi et al., 2012).  
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2. AIMS OF THE STUDY 
 
 
The aim of the study was to quantify the gut microbial compositions of healthy persons in 
different age groups.  
The present study set the following specific objectives: 
1. Elaboration of real-time PCR method for quantitative analysing of twelve bacterial groups 
of the human gut 
2. Assessment the counts of dominanat bacterial groups 
3. Assessment the ratio of Bacteroides/Firmicutes  
4. Assessment the counts of beneficial bacterial groups such as Lactobacillus and 
Bifidobacterium sp. in different age groups 
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3. MATERIALS AND METHODS 
 
3.1 Study groups  
The study group comprised both twenty five healthy 1- and 5-year-old children who were 
randomly selected from a large group in which the immune responses to allergens and the 
develpment of allergy were studied (Julge et al., 2001). Adult were recruited from the 
baseline values of the study assessing the impact of a probiotic product (Mikelsaar et al., 
2014, submitted). Elderly were selected from the registry of family doctors and orthopaedists 
of the Tartu University Hospital, Estonia, before performing elective orthopaedic surgery 
(Mikelsaar et al., 2010) (Table 1). The studies were approved by the Ethics Committee of the 
Medical Faculty of the University of Tartu with approvals no. ISRCTN38739209, 139/16 
20.06.2005; 158/10 26.03.2007; ISCRNT53154826. Informed consent was also obtained from 
the parents of the children. 
Table 1. Characterization of the study groups. 
 Infants Children Adults Elderly 
Subjects 
(male/female) 
25 (17/8) 25 (13/12) 25 (4/21) 23 (9/14) 
Age (mean±SD) 
(months/years 
old) 
11.9±0.6  63.7±2.5  48.2±6.6  72.9±5.0  
SD - standard deviation. Age of infants and children present in months; adults and elderly in years. 
 
 
3.2 Bacterial strains and culture conditions 
3.2.1 Sample collection 
Fresh stool samples were placed in a plastic cups. The samples collected at home were kept in 
a domestic refregerator at 4°C for no more than 2h before transportation to the laboratory, 
where the plastic cups were stored frozen at -70°C until use. 
3.2.2 The reference strains 
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Twelve culture collection strains were purchased from both the American Type Culture 
Collection (ATCC) and the Deutsche Sammlung von Mikroorganismen und Zellkulturen 
(DSMZ). Bacterial fecal isolates identified by MALDI TOF MS spectrophotometer has been 
used in this study (Table 2).  
 Table 2. The reference strains used in the study. 
 
 
3.3 DNA extraction 
Bacterial DNA of type strains was extracted using QiaAmp DNA mini kit (Qiagen, Hilden, 
Germany) according to manufacture instructions. 
Bacterial DNA from faecal samples was extracted using a QIAamp DNA stool mini kit 
(QIAgen, Hilden, Germany) with some modifications. 180-220 mg of faeces were 
resuspended in 200 µl of TE buffer (10 mMTris, 10 mM EDTA pH=8, 20 mg/ml lysozyme, 
200 u/ml mutanolysin) and incubated for 1 hour at 37ºC. 0.3 g of 0.1 mm zirconia/silica beads 
and 1.4 ml of ASL solution from the stool mini kit was added to faecal samples. The tubes 
were then agitated for 3 min at a speed of 5000 rpm in a mini-bead beater (Biospec Products 
Inc., USA). The protocol was continued according to manufacture instructions. Extracted 
DNA was quantified using NanoDrop™ 1000 Spectrophotometer 1.0 (NanoDrop 
Technologies, Inc., USA) at 260 nm. 
 
3.4 Primers and probes 
Primers and probes used in the study were targeted on the 16S rRNA genes (Table 3). The 
oligonucleotide probe used for the detection of the genus Bifidobacterium and Lactobacillus 
Species Strain 
E. coli 
E.coli 
B. longum 
B. fragilis 
 
C. perfringens 
R. gvanus 
 
C. leptum 
C. difficile 
B. bifidum 
L. acidophilus 
E. faecalis 
V. parvula 
F.prausnitzii 
ATCC 700336 
JM109 
DSM14583 
MALDI-TOF(B.fragilis,2.3 
score) 
DSM 756 
MALDI-TOF(R.gvanus,2.3 
score 
DSM 753 
ATCC 43255 
DSM 20456 
ATCC 4356 
ATTC 51299 
DSM 2007 
DSM 17677 
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are labeled with the 5 reporter dye VIC and the 3 quencher NFQ-MGB and for total bacteria 
and C. difficile with 6-FAM and TAMRA (Applied Biosystems, The Netherlands).
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Table 3. Table of primers and probes used in the study. 
Target groups (amplicon 
length, Tm, assay) 
Primers/Probes Sequence (5’-3’) References 
All bacteria  (466bp, 60ºC, 
TaqMan) 
 
 
 
 
Firmicutes phylum (126bp, 
60°C, Sybr Green) 
 
 
Bifidobacterium spp.(231bp, 
60°C TaqMan) 
 
 
 
 
 
Lactobacillus spp.(92bp, 60°C 
TaqMan) 
 
 
 
 
Bacteroides-Prevotella group 
(140bp, 58ºC, Sybr Green) 
 
C. perfringens group (120bp, 
55ºC, Sybr Green) 
 
 
C. coccoides-E.rectale group 
(182bp, 55ºC, Sybr Green) 
 
C. leptum group (239bp, 50ºC, 
Sybr Green) 
 
C. difficile (177bp,60 ºC, 
TaqMan) 
 
 
 
 
 
 
Enterobacteriacea  
(195bp ,58°C, Sybr) 
 
 
Enterococcus spp. (144bp, 
61°C Sybr) 
 
 
Veilonella spp. (343bp, 62°C, 
Sybr Green) 
 
F. prausnitzii (158bp, 61°C , 
Sybr Green) 
 
Eub-f 
Eub-r 
Eub (Probe) 
 
 
 
Firm934f 
Firm1060r 
 
 
Allbif-f 
Allbif-r 
AllBif(Probe) 
 
 
 
 
AllLacto-f 
AllLacto-r 
AllLacto(Probe) 
 
 
 
Bact-f 
Bact-r 
 
Cperf-f 
Cperf-r 
 
 
Ccocc-r 
Ccocc-f 
 
Clept-f 
Clept-r 
 
Cdif398 
Cdif399 
Cdif(Probe) 
 
 
 
 
 
Eco1457-f 
Eco1652-r 
 
 
Enteroc-f 
Enteroc-r 
 
 
Veilon-f 
Veilon-r 
 
Fprau-f 
Fprau-r 
TCCTACGGGAGGCAGCAGT 
GGACTACCAGGGTATCTAAT
CCTGTT 
(6-FAM)-
CGTATTACCGCGGCTGCTGG
CAC-(TAMRA) 
GGAGYATGTGGTTTAATTCG
AAGCA 
AGCTGACGACAACCATGCA
C 
GGGATGCTGGTGTGGAAGA
GA 
TGCTCGCGTCCACTATCCAG
T 
(VIC)-
TCAAACCACCACGCGCCA-
(NFQ-MGB) 
TGGATGCCTTGGCACTAGGA 
AAATCTCCGGATCAAAGCTT
ACTTAT 
(VIC)-
TATTAGTTCCGTCCTTCATC-
(NFQ-MGB) 
GGTGTCGGCTTAAGTGCCAT 
CGGACGTAAGGGCCGTGC 
 
ATGCAAGTCGACCGAKG 
TATGCGGTATTAAATCTYCC
TTT 
 
AGTTTYATTCTTGCGAACG 
CGGTACCTGACTAAGAAGC 
 
GCACAAGCAGTGGAGT 
CTTCCTCCGTTTTGTCAA 
 
GAAAGTCCAAGTTTACGCTC
AAT 
GCTGCACCTAAACTTACACC
A 
(6-
FAM)ACAGATGCAGCCAAAG
TGGTTG 
AATT-(TAMRA) 
CATTGACGTTACCCGCAGAA
GAAGC 
CTCTACGAGACTCAAGCTTG
C 
CCCTTATTGTTAGTTGCCAT
CATT 
ACTCGTTGTACTTCCCATTG 
 
A(C/T)CAACCTGCCCTTCAGA 
CGTCCCGATTAACAGAGCTT 
 
GTCGCAGGATGTCAAGAC 
CCCTTCAGTGCCGCAGT 
Nadkarni et al., 2002 
 
 
 
 
 
Guo et al., 2008 
 
 
 
Haarman et al., 2007 
 
 
 
 
 
 
Haarman et al., 2007 
 
 
 
 
 
Malinen et al., 2005 
 
 
Malinen et al., 2005 
 
 
 
Malinen et al., 2005 
 
 
 
Matsuki et al., 2004 
 
 
Berg et al., 2007 
 
 
 
 
 
 
Bartosch et al., 2004 
 
 
 
Malinen et al., 2005 
 
 
 
Malinen et al., 2005 
 
 
Malinen et al., 2005 
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3.5 Plasmids construction and standards. 
In order to establish a quantitative assays, we cloned plasmids containing the amplified region 
of target bacteria using the pGEM-T Easy vector system (Promega, Madison, USA). The PCR 
amplicon for each reference strain was individually inserted into a separate plasmid vector; 
the recombinanat vector was transformed into chemically competent E. coli JM109 cells. 
Plasmids were purified with NucleoSpin PlasmidQuick pure Kit according to manufacture 
instruction (Macherey-Nagel, Germany). The purified plasmids were quantified by 
spectrofotometry (NanoDrop ND-1000, USA) of multiple dilutions (Bartosch et al., 2004; 
Fite et al., 2004). Quantification of target DNA was achived by using serial tenfold dilution 
from 105 to 101 plasmid copies of the previously quantified plasmid standards.  
 
3.6 Real-time PCR method (qPCR) 
Amplification and detection of DNA by real-time  PCR was performed with a 7500 Fast Real-
Time PCR System (Applied Biosystems Europe BV, Zug, Switzerland) using optical-grade 
96-well plates. Duplicate sample analysis was routinely performed in a total volume of 25 µl 
using SYBR Green PCR Master Mix (Applied Biosystems). Each reaction included 2µl of 
template DNA, 12.5µl of SYBR Green Master mix (Applied Biosystems, USA) and 100-400 
mM of forward and reverse primers. The end of PCR assays dissociation curve analysis was 
performed to check for non-specific products and/or contamination for SYBR Green. 
For TaqMan assay PCR reaction was performed in a total volume of 25µl using the TaqMan® 
Universal PCR Master Mix (Applied Biosystems, USA). Each reaction included 2µl of 
template DNA, 12.5µl of TaqMan® Universal PCR Master Mix (Applied Biosystems, USA), 
400 nM of forward and reverse primers, 100 nM of corresponding probe. The real-time PCR 
conditions consisted of an initial denaturation step 50°C for 2 min and 95°C for 10 min, 
continued with amplification step followed by 40 cycles consisting of denaturation at 95°C 
for 15 s, annealing-elongation step at 60°C for 1 min.  Standard curves were routinely 
performed for each real-time PCR run using serial dilutions of control plasmid DNA. Data 
from triplicate samples were analyzed using the Sequence Detection Software version 1.6.3 
(Applied Biosystems, USA). 
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3.7 Statistical analysis 
The statistical analysis was performed using SIGMASTAT 2.0 (Jandel Scientific Corporation, 
San Safael, CA, USA). Data are present as means and standard deviation or ranges and 
medians. The prevalence of the species was expressed by as a percentage. According to the 
data descriptive statistics, Fisher exact test, Bonferron correlation and Mann-Whitney rank 
sum test were applied to compare the differences in microbiological indices. All differences 
were considered statistically significant if p<0.008. 
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4. RESULTS 
4.1 Elaboration of real-time PCR method  
To check the reliability of the QIAamp DNA Stool Mini kit (Qiagen) and to determinate a 
detection limit of the real-time PCR method, a recovery experiment was performed. Faecal 
samples, in which Bifidobacterium sp. could not be detected, were dosed with aliquots of 
different dilutions of lactobacilli (DSM 20456; 106–0 CFU/ml). DNA isolation was 
undertaken and real-time PCR analysis of the samples was performed to determine the 
amount of bifidobacteria. Additionally, electrophoresis on agarose gel was performed to 
confirm the results.  
A standard curve was obtained by using 10-fold serial dilutions of positive plasmids for all 
target microorganisms. The real-time PCR assay was able to detect 3·105-3·101 plasmid 
copies. To generate a standard curve, the threshold cycle (Ct) of these standard dilutions was 
plotted against the number of plasmid copies used as input. The copy numbers of the target 
group for each reaction were calculated from the standard curves. The functions describing 
the relationship between Ct (threshold number) and x (copy number) for Firmicutes phylum 
were:  Ct= -3.17x+37.79; R2=0.99; Bacteroides-Prevotella group: Ct= -2.55x+34.4; R2=0.99; 
C. perfringens Ct= -2.89x+34.83; R2=0.98, C.leptum group: Ct= -2.81x+41.66; R2=0.99, C. 
coccoides group: Ct= -3.48x+42.08; R2=0.99; C.difficile: Ct= -3.12x+31.55; R2=0.99; 
Enterobacteriaceae Ct=  -3.62x+39.08; R2=0.99; Enterococcus sp. Ct= -3.07x+38.7; R2=0.98; 
Lactobacillus sp. Ct= -3.07x+34.99; R2=0.99, Bifidobacterium sp. Ct= -3.87x+46.52; 
R2=0.98;  Veillonella group Ct= -3.08x+36.25; R2=0.99; F. prausnitzii Ct= -2.17x+30.83; 
R2=0.98. 
Table 4. Most prevalent bacterial groups in human gastrointestinal tract detected by real-time 
PCR in this study. 
RT-PCR assay Target species 
Firmicutes phylum 
 
 
 
 
Bacteroides-Prevotella- 
Porphyromonas group 
 
 
 
 
Bacillaceae, Paenibacillaceae, Staphylococcaceae, 
Aerococcaceae, Lactobacillaceae, Leuconostocaceae, 
Streptococcaceae, Acidaminococcaceae, Closridiaceae, 
Eubacteriaceae, Lachnospiraceae, Peptococcaceae, 
Peptostreptococcaceae, Erysipelotrichaceae family 
Bacteroides fragilis, B.stercoris, B.vulgatus, B.eggerthii, 
B.acidofaciens, B.caccae, B.ovatus, B.uniformis, 
B.thetaiotaomicron, B.distasonis, B.merdae, B.forsythus, 
Prevotella tannerae, P.bryantii, P. ruminicola, P. 
heparinolytica,P. zoogleoformans, P. brevis, P. loescheii, P. 
buccae, P. oralis, P. enoeca, P. melaninogenica, P. veroralis, P. 
29 
 
 
 
 
 
C. perfringens group 
 
 
 
 
 
 
 
 
 
 
C. coccoides-E.rectale 
group 
 
 
 
 
 
 
 
 
 
 
 
 
C. leptum group 
 
 
 
 
C. difficile 
Enterobacteriacea 
 
 
 
 
 
 
 
 
 
 
Bifidobacterium sp. 
 
 
 
 
intermedia, P. albensis, P. nigrescens, P. corpois, P. disiens, P. 
bivia, P. pallens, P. denticola, Parphyromonas canoris, P. 
gingivalis, P.asaccharolytica, P.levii, P. cangingivalis, P. 
macacae, P. circumdentaria, P. catoniae 
Clostridium perfringens, C. homopropionicum, C. cadaveris, C. 
intestinalis, C. putrificum, C. botulinum, C. novyi, C. 
sporogenes, C. tyrobutyricum, C. kluyveri, C. ljungdahlii, C. 
scatologenes, C. acetireducens, C. subterminale, C. 
estertheticum, C. agrentinense, C. sardiniensis, C. 
paraputrificum, C. longisporum, C. septicum, C. cellulovorans, 
C. barati, C. absonum, C. chauvoei, C. carnis, C. butyricum, C. 
beijerinckii, C. kainantoi, C. corinoforum, C. puniceum, C. 
histolycum, C. proteolyticum, C. limosum, C. paraputrificum, 
Eubacterium budayi, E. nitritogenes, E. moniliforme, E. 
multiforme 
Clostridium coccoides, C. proteoclasticum, C. aminophilum, C. 
symbiosum, C. sphenoides, C. celerecrescens, C. aerotolerans, 
C. xylanolyticum, C. clostridiiforme, C. fusiformis, C. nexile, C. 
oroticum, C. populeti, C. aminovalericum, C. indolis, C. 
herbivorans, C. polysaccharolyticum, Eubacterium 
xylanophilum, E. ruminantium, E. saburreum, E. fussicatena, E. 
hadrum, E. rectale, E. ramulus, E. contortum, E. eligens, E. 
hallii, E. formicigenerans, E. cellulosolvens, Rumminococcus 
products, R. obeum, R. schinkii, R. hydrogenotrophicus, R. 
hansenii, R. torques, R. lactaris, R. gvanus, Butyrivibrio 
fibrisolvens, B. crossotus, B. fibrisolvens, Desulfotomaculum 
guttoideum, Roseburia cecicola, Pseudobutyrivibrio ruminis, 
Lachnospira multipara, L. pectinoschiza, Acetitomaculum 
ruminis, Catonella morbi 
Clostridium leptum, C. sporosphaeroides, C. cellilosi, C. viride, 
R. flavefaciens, R.callidus, R.albus, Eubacterium siraeum, E. 
plautii, E. desmolans, E.bromii, Butyrate-producing bacterium, 
Faecalibacterium prausnitzii, Subdoligranulum variable, 
Anaerofilum agile, A.pentosovorans, Sporobacter termitidis  
Clostridium difficile 
Moellerella wisconsensi, Providencia alcalifaciens, P. 
rustigianii, P. rettgeri, P.stuartii, Proteus penneri, P. mirabilis, 
P. vulgaris, Morganella morganii, Leminorella grimontii, 
Edvardsiella tarda, Escherichia coli, E. fergusonii, Citrobacter 
koseri, C. amaloonaticus, C. farmeri, C. sedlakii, Serratia 
marcescens, S. liquefaciens, Klebsiella pneumoniae, K. oxytoca, 
Citrobacter murliniae, C. amalonaticus, C. farmeri, C. sedlakii, 
Raoultella planticola, R. Terrigena, Enterobacter aerogenes, E. 
cancerogenus, E. cloacae, E. asburiae, Pantoea agglomerans, 
Tatumella ptyseos, Averyella dalhousiensis, Yokenella 
regensburgei  
B. longum, B.minimum, B. angulatum, B. catenulatum, B. 
dentium, B. ruminantium, B. thermophilum, B. subtile, B. 
bifidum, B.boum, B. lactis, B. animalis, B. choerinum, B. 
gallicum, B. pseudolongum subsp. globosum, B. pseudolongum 
subsp. pseudolongum, B. magnum, B. infantis, B. gallinarum, B. 
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Lactobacillus group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enterococcus sp. 
 
 
 
 
 
Veilonella spp.  
 
F. prausnitzi 
pullorum, B. saeculare, B. suis 
Lactobacillus acidophilus, L. amylovorus, L. delbrueckii subsp. 
bulgaricus, L. delbrueckii subsp. delbrueckii, L. delbrueckii 
subsp. lactis, L. amylolyticus, L. acetotolerans, L. crispatus, L. 
amylophilus, L. johnsonii, L. gasseri, L. fermentum, L.pontis, L. 
reuteri, L. mucosae, L. vaginalis, L. panis, L. oris, L. pentosus, 
L. plantarum, L. collinoides, L. alimentarius, L. farciminis, L. 
brevis, L. buchneri, L. kefiri, L. fructivorans, L. mali, L. 
animalis, L. murinus, L. ruminis, L.agilis, L. salivarius, L. 
aviarius, L. sharpeae, L. manihotivorans, L. rhamnosus, L. 
casei subsp. casei, L. casei subsp. fusiformis, L.zeae, L. 
paracasei subsp. paracasei, L. paracasei subsp. tolerans, L. 
coryniformis subsp. coryniformis, L. bifermentas, L. perolens, 
L. sakei, Pediococcus pentosaceus, P. parvulus, P. acidilactici, 
P. dextrinicus, Weissella halotolerans, W. confusus, W. 
paramesenteroides, W. hellenica, W. viridescens, W. kandleri, 
W. minor, Leuconostoc lactis 
Enterococcus faecalis, E. faecium, E. asini, E. saccharolyticus, 
E. casseliflavus, E. gallinarum, E. dispar, E. flavescens, E. 
hirae, E. durans, E. pseudoavium, E. raffinosus, E. avium, E. 
malodoratus, E. mundtii, E. azikeevi, E. canis, E. gilvus, E. 
haemoperoxidus, E. hermanniensis, E. moraviensis, E. pallens, 
E. phoeniculicola, E. villorum, E. rottae 
Veilonella parvula, V. dispar, V. atypica, V. ratti, V. criceti, V. 
rodentium, V. caviae 
Fusobacterium prausnitzii 
 
4.2 Quantitative differences between the gut microbiota of infants, children, adults and 
elderly 
Using real-time PCR, a total 12 bacterial groups were quantified from faecal samples of four 
age groups. Totally 14 families of Firmicutes phyla and more than 290 species were detected 
in faecal samples (Table 4). The large inter-individual variation in the numbers of bacteria 
detected from faecal samples of the 98 subjects was assessed. Results real-time PCR test are 
present in Figures 5-9, Table 5. Firmicutes phylum, Enterobacteriaceae, Bacteroides-
Prevotella, C. perfringens, C.leptum, C. coccoides, Veillonella groups and Enterococcus sp. 
were detected in all faecal samples. 
The most prevalent phyla were Firmicutes and Bacteroides in all groups. The level of 
Firmicutes phylum increased while Bacteroides-Prevotella groups decreased with age (Figure 
5 А, B). The highest counts of bacteria belongs to Firmicutes phyla were found in elderly in 
comparison to infants (1.6·1011-2.9·108; median 1.6·1010 vs. 4.4·109-5·108; median 1.47·109; 
p<0.001) (Figure 5A). In opposite, elderly were less colonized with Bacteroides-Prevotella 
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group in comparison to adults and infants (1.45·10
9
-8·10
2
; median 1.33·10
7
 vs. 1.99·10
11
-
3.6·10
4
; median 3.5·10
9
; 5.9·10
11
-3.7·10
4
; median 1.73·10
10
; p<0.001, respectively) (Figure 
5B). 
 
Figure 5. The count of the Firmicutes phyla (A) and the Bacteroides-Prevotella group (B) in 
different age groups 
 
4.3 The ratio of Firmicutes/Bacteroides  genus in different age groups 
The Firmicutes/Bacteroides genus ratio in all studied age groups was observed. The ratio 
increased with age. The ratio were significant statistically lower for infants in comparison to 
children and elderly (1.97-0.79, median 0.9 vs. 2.39-0.96, median 1.29; vs. 3.57-1.12, median 
1.41, respectively; p<0.001) and for adults in comparison to elderly (2.2-0.75, median 1.01 
vs3.57-0.57, median 1.41; p<0.001) (Figure 6).  
32 
 
 
Figure 6. The Firmicutes/Bacteroides ratio in different age groups. Dot plots indicate max-min, 
median, and 1
st
 and 3
rd
 quartiles. 
In total, four dominant Clostridium groups of human intestinal microbiota were detected in 
this study (C. leptum, C. perfringens, C. coccoides-E. rectale and C. difficile). C. leptum and 
C. coccoides-E.rectale groups were prevalent in all age groups. The counts of C. perfringens 
and C. cooccoides-E.rectale group’s were found to be significantly lower in elderly (p<0.001; 
p<0.001, respectively) (Figure 7 A, B). The data have shown that significant higher numbers 
of C. leptum were observed in adults in comparison to elderly and infants (2,40·10
12
-1,83·10
5
, 
median 1,82·10
11
, p=0.007 vs. 7,77·10
7
-7,21·10
8
, median 6,19·10
9
, p<0.001  vs. 7,77·10
7
-
7,21·10
8
, median 6,19·10
9
, p=0.007; respectively) (Figure 7C). 
C. difficile was detected only in three age groups (infants, children and elderly). C. difficile 
was more prevalent in elderly and infants than in adults (10/23, 7/25 (28%) vs. 0/25, p=0.005; 
p<0.001, respectively) (Table 5). The differences in the C. difficile counts between different 
age groups were not found.  
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Figure 7. The counts of C. perfringens group (A), C.coccoides-E.rectale group (B); C. leptum 
group (C), Veillonella group (D), F. prausnitzii (E), Enterobacteriaceae family  (F), Enterococcus 
sp. (G) per gram of faeces determined by real-time PCR. Dot plots indicate max-min, median, and 
1
st
 and 3
rd
 quartiles 
Significant higher numbers of Enterococcus sp. were observed in infants versus adults and 
elderly (2.88·10
8
-1.2·10
7
; median 2.76·10
7
 vs. 6.37·10
9
-1.27·10
6
; median 3.8·10
6
; 1.25·10
8
-
2.2·10
3
; median 8.2·10
5
; p<0.001, respectively) (Figure 7G).  
The highest counts of Enterobacteriaceae family are found in infants. Statistical analysis of 
the data demonstrates progression between age groups with decreasing in children (p=0.004) 
and stabilizing of levels in adults and elderly (p<0.001) (Figure 7F).  
The highest counts of F.prausnitzii were found in adults in comparison to other groups 
(5·10
10
-1.98·10
7
; median 1.34·10
9
 vs. 3.04·10
8
-2.34·10
6
; median 3.6·10
7
; 5·10
9
-7.6·10
2
; 
median 2.7·10
7
; 1.6·10
9
-1.21·10
7
; median 8.18·10
7
; p<0.001, respectively) (Figure 7E). 
Statistical analysis has shown that infants and adults were more harbored Veillonella sp. than 
elderly (2.6·10
9
-5.1·10
5
; median 9.1·10
7
; 1.37·10
9
-7.3·10
3
; median 7.9·10
6
; vs. 1.27·10
7
-
1.6·10
3
; median 8.6·10
5
; p<0.001, respectively) (Figure 7D). 
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Table 5. The prevalence and counts of C. difficile in different age groups.  
 Infants Children Adults Elderly 
Prevalence (%) 7/25 (28%) 5/25 (20%) 0/25 (0%) 10/23 (43.4%) 
Counts (gene copy 
number/g feces) 
(mean±SD) 
2.38·103±2·103 27.4±7.3 ND 227±37 
 
 
4.4 Counts of beneficial bacterial groups (Lactobacillus and Bifidobacterium sp.) 
Real-time PCR analysis detected Bifidobacterium and Lactobacillus species in all fecal 
samples of different age groups. The significant statistical differences were found between 
Bifidobacterium sp. counts in children and adults groups (1.12·109-8.6·105; median 5.8·107 
vs. 7.2·108-2.08·104; median 1.48·107; p=0.007) (Figure 9A). The differences in counts of 
lactobacilli were found between all study groups. Significantly lower amounts were observed 
in adults in comparison to elderly and children (1.10·107-4.5·103; median 5.0·105 vs. 9.8·108-
4.5·106; median 5.6·107; vs. 6.28·108-1·106; median 3.28·107, respectively, p<0.001). Infants 
were less harboured with lactobacilli in comparison to children and elderly (6.04·108-5.5·103; 
median 7.2·106 vs. 6.28·108-1·106; median 3.28·107; vs. 9.8·108-4.5·106; median 5.6·107, 
respectively, p<0.001) (Figure 9B). 
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Figure 9. The gene copies numbers of total Bifidobacterium sp. (A) and total Lactobacillus sp. (B) 
per gram of faeces determined by real-time PCR. Dot plots indicate max-min, median, and 1
st
 and 
3
rd
 quartiles.  
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5. DISCUSSION 
The intestinal microbiota plays an important physiological role in human health and changed 
with age. Although the knowledge about composition of intestinal microbes is still limited, 
this study allowed more detailed to describe the complex composition of human intestinal 
microbiota in different ages. For that the dominant groups of human intestinal microbiota has 
been quantified by using real-time PCR. Our study have demonstrated that human intestinal 
microbiota have high individual diversity. Previously has been shown that ageing has been 
associated with profound changes in the bacterial colonisation as well as metabolic activities 
in the colonic ecosystem (Zwielehner et al., 2009; Claesson et al. 2011). Several factors may 
influence on diversity and stability of the intestinal microbial community such as 
geographical location, exposure to peristaltic activity, food molecules and gastric secretion 
(Manson et al., 2008).  
All samples show very comparable overall structure of intestinal microbiota, that confirms the 
modern confirmation about increased of Firmicutes phylum and decreased of Bacteroides 
phylum among the age groups (Mariat et al., 2009). In our study we found that 
Firmicutes/Bacteroides ratio increased with age. Previously, increase in the 
Firmicutes/Bacteroides ratio was demonstrated for persons with obesity (Ley et al., 2005; 
Cani et al., 2009). Larsen et al. (2010) has shown also the positive correlation between the 
ratios of Firmicutes/Bacteroides and plasma glucose. However, the European study of adults 
and elderly (age groups 20-50 years and >60 years) by using FISH-flow cytometry have 
demonstrated country specific age related differences in the gut microbiota composition. The 
level of Bacteroides–Prevotella group was higher in elderly in Germany but lower in Sweden 
and Italy (Mueller et al., 2006). 
Our study has shown a decrease in C. perfringens and C.coccoides-E.rectale groups with 
ageing. Similar results have been demonstrated for Japan, Italian and Finnish elderly (Hayashi 
et al., 2003; Mueller et al., 2006; Mäkivuokko et al., 2010). The study using a phylogenetic 
microarray also has demonstrated that members of Clostridium sp. and Bacteroides genus 
lower abundant in elderly (Gerritsen et al., 2011).  
Interesting results have been demonstrated for F.prausnitzii and C. leptum group. 
F.prausnitzii belongs to the phylum Firmicutes and is the major bacterium of the C. leptum 
group (Cao et al., 2014). Our study has demonstrated that the amount of both groups was 
increased in adults.  
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There are not studies about quantitative changing of C.leptum group during ageing in healthy 
persons. The interest in studying of F.prausnitzii increased recently because this bacterium 
has anti-inflammatory properties in the gut (Sokol et al., 2008). Swedish study has found to 
have highest numbers of Fusobaterium prausnitzii which was associated by high consumption 
of fish and meat (Mueller et al., 2006). 
Previous studies suggested that asymptomatic colonization with C. difficile early in life is 
more common in infants who develop allergy diseases (Penders et al., 2007). C.difficile is a 
normal gut resident that can cause disease after treatment with antibiotics in stable adults gut. 
The quantitative composition of intestinal microbiota in children and adults was a quite 
similar. It has been shown that the diversity of gut microbiota increases and becomes stable 
by the first three-five years of life (Koenig et al., 2011). In this study we used fecal samples of 
5 years old children. However, the significant differences were found in Bifidobacterium sp., 
Lactobacillus sp. and Enterococcus sp. The detection of Bifidobacterium sp. from samples of 
infants and children is consistent with the earlier findings that gut microbiota is dominated by 
facultative anaerobes in both groups as compared to adults microbiota and its one of early 
anaerobic colonizers of infant gut (Ouwehand et al., 2001). The Bifidobacterium sp. of the gut 
may differentially exert antimicrobial activity, suggesting their participation in the 
‘colonization resistance’ produced by indigenous microbiota (Lievin et al., 2000).  
The large changes in the counts of Lactobacillus sp. was found for all study groups. 
Previously, the increase in prevalence in number of Lactobacilllus sp. during aging has been 
described (Tiihonen, 2008). The increase of viable counts of lactobacillus in elderly 
individuals in comparison with younger adults also has been shown (Mikelsaar et al., 2010, 
Mäkivoukko et al., 2010; Štšepetova et al., 2011). Lactobacillus sp. comprised a minor part of 
the bacterial community in human gut (Sghir et al., 2000). The role of lactobacilli has 
received much attention, especially due to their putative properties. It has been shown that 
Lactobacillus sp. contribute to digestion, stimulation of immunity and impact on metabolism 
and energy uptake in the host (Vaughan et al., 2004, Valeur et al., 2004, Cani and Delzenne, 
2009). 
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6. CONCLUTION 
The study presented here we applied real-time PCR method to characterise and examine the 
human intestinal microbiota of healthy persons in different age groups. Our results confirmed 
that real-time PCR is powerful technique in the quantitative study of human intestinal 
microbiota. The statistical analysis allowed obtaining the information about the impact of the 
ageing process on the gut microbiota composition. 
Our results showed that Firmicutes phyla and Bacteroides-Prevotella goup were prevailed in 
all age groups. The highest counts of bacteria belong to Firmicutes phyla were found in 
elderly. The Firmicutes/Bacteroides sp. ratio undergoes an increase from birth to adults and is 
further altered with advanced age.  
C.leptum and C.coccoides-E.rectale groups were highly represented in all groups. Clostridium 
sp. counts decreased with ageing. Mucus-degrading C.difficile was detected in three age 
groups (infants, children, elderly) with highest counts in infants. The counts of Enterococcus 
sp., Veillonella sp. and Enterobacteriaceae were higher in infants while F.prausnitzii in 
adults. 
The microbiota of elderly was generally characterized by high counts of beneficial 
lactobacilli. Adults and infants were less colonised with lactobacilli comparison to children. 
The differences in the colonization with Bifidobacterium sp. were found between children and 
adults. 
Our study demonstrated that the composition of intestinal microbiota evolves through life, 
from early childhood to old age with remarkable similarity between children and adults. We 
tried to output  approximately the norms in the counts of bacteria in gut of healthy persons in 
different ages, but it was quite complicated through high microbial inter-individual diversity. 
In the future studies it is possible to perform comparable analysis of the gut microbial 
composition between healthy people and people with different disorders. Thus, by using this 
data development of the effective treatment and therapies is possible in the case of 
inflammatory bowel diseases (e.g. Crohn's Disease, ulcerative colitis), metabolic syndrome, 
autoimmune diseases, anaemia and different infectious diseases. 
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7. Erinevate vanuserühmade tervete inimeste soolestiku mikroobikoosluse molekulaarne 
kvantitatiivne analüüs 
Natalja Šebunova 
Resümee 
Antud töös rakendasime real-time PCR meetodit erinevate vanuserühmade tervete inimeste 
soolestiku mikroobikoosluse iseloomustamiseks. Meie tulemused kinnitasid, et real-time PCR 
on võimas meetod inimese soolestiku mikrofloora kvantitatiivsel uurimisel. Statistiline 
analüüs võimaldas hinnata vananemisprotsessi mõju soolestiku mikrofloora koosseisule. 
Meie tulemused näitasid, et kõikides vanuserühmades olid kõige kõrgema 
esinemissagedusega Firmicutes hõimkond ja Bacteroides-Prevotella rühm. 
Firmicutes/Bacteroides sp. suhe suureneb sünniajast täisealisuseni ja muutub kõrges eas. 
C.leptum ja C.coccoides-E.rectale rühmad olid kõrgelt esindatud kõikides rühmades. 
Clostridium sp. arv vähenes inimese organism vananemisega. Soolestiku epiteeliumi 
limaskesta lagundav C.difficile tuvastasime kolmes rühmas (imikus, lapsed, vanurid), kõige 
suurema esinemissagedusega imikutel. Enterococcus sp., Veillonella sp. ja 
Enterobacteriaceae  sugukonna hulgad olid kõige kõrgemad imikutel, samas F.prausnitzii oli 
arvukaim täiskasvanutel. Vanurite soolestiku mikroobikooslust iseloomustab kasulike 
lactobacillide suured arvud. Täiskasvanutel ja imikutel oli koloniseeritus laktobatsillidega 
kõrgem võrreldes lastega, samuti olid suured erinevused bifidobakteriga koloniseerumisel 
lastel ja täiskasvanutel. 
Meie uuring näitas, et soolestiku mikrofloora areneb läbi elu, alates varasest lapsepõlvest kuni 
vanaduseni, tähelepanuväärsuse sarnasusega lastel ja täiskasvanutel. Meie proovisime 
selgitada mikroobide tavapäraseid hulkasid tervete isikute eri vanuses, kuid see oli üsna 
keeruline mikroobide suure interindividuaalse mitmekesisuse tõttu. Tuleviku uuringutes on 
võimalik teostada tervete ja erinevate haigustega inimeste soolestiku mikroobse 
kompositsiooni võrdlevat analüüsi. Seega, kasutades meie saadud andmeid on võimalik 
arendada efektiivset ravi ja teraapiad selliste haiguste puhul nagu põletikulised soolehaigused 
(nt Crohni tõbi, haavandiline koliit), metaboolne sündroom, autoimmuunhaigused, anaemia ja 
erinevad soolenakkushaigused. 
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